查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1933914

输尿管支架系统市场（按材料、产品类型、适应症、最终用户和分销管道划分），全球预测，2026-2032年

Ureteral Stent System Market by Material, Product Type, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，输尿管支架系统市场价值将达到 10.6 亿美元，到 2026 年将成长至 11.5 亿美元，到 2032 年将达到 18.4 亿美元，年复合成长率为 8.16%。

关键市场统计数据
基准年 2025 10.6亿美元
预计年份：2026年 11.5亿美元
预测年份 2032 18.4亿美元
复合年增长率 (%) 8.16%

权威深入分析了影响现代输尿管支架系统决策的临床重点、设备发展历程和营运驱动因素。

输尿管支架系统在泌尿系统治疗中继续发挥至关重要的作用，它能够引流上泌尿道积水，适用于多种适应症，包括阻塞性结石、恶性肿瘤压迫以及良性狭窄。近年来，技术的进步使该领域从简单的聚合物管发展到采用先进材料、表面处理和几何设计的装置，旨在提高患者舒适度、减少结石嵌顿并延长支架留置时间。临床医师和医疗系统管理者在评估支架选择时，不仅关注其即时临床疗效，也越来越重视其对后续治疗的影响，例如再入院率、再次手术率和总医疗成本。

材料科学、抗菌技术和不断发展的医疗保健服务模式的进步如何重新定义输尿管支架系统的临床实践和商业策略

输尿管支架系统正经历多重变革的重塑，这些变革涵盖临床、技术和组织等多个面向。材料科学的进步，例如可生物降解聚合物和表面光洁度更高的镍钛合金，正在催生新的产品类型，旨在减少结石沉积和移位等併发症。同时，药物释放型涂层和抗菌表面技术的进步正在应对感染和生物膜的风险，使临床医生能够考虑将支架疗法应用于更广泛的适应症和更长的治疗週期。此外，积层製造和精密工程技术的进步也为更个人化的支架几何形状和患者特异性解决方案开闢了道路，儘管监管和规模化生产仍然是实际操作中的限制因素。

新累积关税对输尿管支架生态系统中的采购、製造韧性和基本契约的营运和策略影响

美国新关税的实施为输尿管支架价值链带来了复杂的挑战，也促使各企业采取相应的策略应对措施。对关键原料和成品组件征收的进口关税增加了依赖全球供应商的製造商的在地采购成本，尤其是在特殊聚合物和金属合金领域。为了应对这些挑战，许多公司已启动策略行动，例如重新谈判供应合约、优化库存以及选择性地将关键生产投入转移到近岸地区，以降低其受跨境关税波动的影响。然而，这些倡议需要前期投资和时间来检验新製造地的品质系统和合规性。

透过深度細項分析，将终端用户、材料创新、设备分类、临床适应症和通路与策略商业化决策联繫起来。

深入了解输尿管支架市场的临床和商业性细分对于推动产品开发和市场推广策略至关重要。从终端使用者角度分析，此市场可分为门诊手术中心、诊所和医院。在门诊手术中心内部，医院所有和医生所有机构各有其特点；而在医院内部，私立和公立机构的采购模式也存在差异。从材料角度来看，产品类别包括可生物降解材料（如聚己内酯和PLGA）、镍钛合金或不銹钢合金製成的金属支架，以及基于PVC或硅胶的聚合物支架。每种材料在生物相容性、柔软性、渗透性和製造工艺复杂性方面各有优缺点。

区域法规环境、报销趋势和医疗服务趋势将如何影响美洲、欧洲、中东和非洲以及亚太地区的医疗服务普及和获取

区域趋势对全球输尿管支架系统的法规结构、报销机制和临床应用模式有显着影响。在美洲，多样化的支付方结构和众多三级医疗中心推动了对差异化器械功能和循证医学证据的需求，这些需求使得较高的单价在后续干预减少的情况下具有合理性。同时，在美洲许多地区，采购决策越来越注重价值主导，强调整体治疗效果而非单纯的器械单价。在欧洲、中东和非洲，一些地区的监管协调和集中采购为能够证明其临床表现稳定且供应链合规的製造商创造了机会。同时，各国报销体系和临床路径的差异也要求製造商采取适应性强的打入市场策略。

领先製造商的策略行动和营运重点在于创新、证据产生和供应链韧性，以确保临床应用。

输尿管支架领域的主要企业正透过自主创新、策略合作和有针对性的收购相结合的方式，建构差异化的产品系列组合，并加速产品上市速度。投资重点通常包括可生物降解的材料平台、可降低黏附和感染风险的涂层表面，以及能够提升患者舒适度和固定效果的设计。此外，各企业也透过研究者主导的临床试验、註册研究合作以及真实世界证据项目，不断增加临床证据的积累，以支持监管申报和与支付方的沟通。这些努力通常辅以商业策略，例如整合临床医生培训计画、手术支援和全面的服务，旨在降低医院系统的实施风险。

为製造商和医疗系统提供可操作的策略重点和营运措施，以加速临床应用并建立具有韧性、以价值主导的经营模式。

产业领导者应优先采取一系列切实可行的措施，使研发、生产和商业性执行与当前的临床和经济需求保持一致。首先，将研发资源集中在能够显着减少併发症的材料和涂层，将增强对支付方和医疗服务提供者的价值提案。同时，对可靠的临床证据和註册登记进行同步投资，将加速产品在门诊和住院环境中的推广应用。其次，透过选择性地进行近岸外包和利用检验的二手讯息，实现生产和采购网路的多元化，将降低关税和物流风险，并确保医疗客户的供应可靠性。第三，企业应完善商业模式，提供效能保证和服务包，整合医疗设备、培训和后续支持，以支援全面的医疗保健合约和按绩效付费的采购计画。

采用透明的研究途径，结合相关人员访谈、临床文献综合、监管检验和资料三角验证，以支持可操作的研究结果。

本执行摘要的研究整合了初步定性研究结果和全面的二手研究，以确保结果的平衡性和检验。初步研究包括对执业泌尿系统、门诊和医院采购人员、临床试验研究人员以及供应链高管进行结构化访谈，以提供关于医疗设备性能、采购因素和临床工作流程的真实观点。二级资讯来源资讯来源同行评审的临床文献、监管申报文件、材料科学出版物、公开的产品标籤和不利事件报告，这些资料用于对材料、涂层和器械结构进行技术评估。

对输尿管支架系统的临床、技术和运作趋势进行简明扼要的总结，阐明其竞争优势和推广路径。

总而言之，输尿管支架系统领域正经历着材料创新、临床实践变革以及人们对价值和安全性日益增长的期望交汇融合的演变。生物可降解聚合物、工程金属结构和抗菌表面技术的进步，在为临床医生拓展治疗选择的同时，也带来了新的生产製造、监管和报销方面的考量。同时，门诊治疗的日益普及、单次治疗成本的压力以及供应链的脆弱性，正迫使製造商将产品开发与可验证的临床疗效和营运韧性相结合。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依材料分類的输尿管支架系统市场

  • 可生物降解
    • PCL
    • PLGA
  • 金属
    • 镍钛
    • 不銹钢
  • 聚合物
    • PVC
    • 硅酮

9. 输尿管支架系统市场（依产品类型划分）

  • 双J
  • 共振金属
  • 自膨胀

10. 输尿管支架系统市场（依适应症划分）

  • 结石疾病
  • 堵塞
    • 良性
    • 恶性
  • 收缩

第十一章 以最终用户分類的输尿管支架系统市场

  • 门诊手术中心
    • 医院所有
    • 医生所有
  • 诊所
  • 医院
    • 私人的
    • 民众

12. 输尿管支架系统市场（依分销管道划分）

  • 电子商务
    • B2B入口网站
    • B2C入口网站
  • 医院销售
  • 零售药房
    • 链
    • 独立的

13. 各地区输尿管支架系统市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 输尿管支架系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国输尿管支架系统市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国输尿管支架系统市场

第十七章 中国输尿管支架系统市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Allium Medical Solutions Ltd.
  • Amecath Medical Technologies
  • Applied Medical Resources Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast A/S
  • Conmed Corporation
  • Cook Medical LLC
  • EuroTec
  • JOLINE GmbH & Co. KG
  • Labotronix
  • Medi-Globe GmbH
  • Merit Medical Systems Inc.
  • Micro-Tech（Nanjing）Co., Ltd.
  • Olympus Corporation
  • Optimed Medizinische Instrumente GmbH
  • Porges SA
  • Rocamed SAS
  • Stryker Corporation
  • Taewoong Medical Co., Ltd.
  • Teleflex Incorporated
  • Urocare Products Inc.
  • Uromedica, Inc.
  • Urotech GmbH
  • Urovision GmbH
Product Code: MRR-C36616F699C1

The Ureteral Stent System Market was valued at USD 1.06 billion in 2025 and is projected to grow to USD 1.15 billion in 2026, with a CAGR of 8.16%, reaching USD 1.84 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.06 billion
Estimated Year [2026] USD 1.15 billion
Forecast Year [2032] USD 1.84 billion
CAGR (%) 8.16%

An authoritative orientation to clinical priorities, device evolution, and operational drivers shaping contemporary ureteral stent system decision-making

The ureteral stent system continues to play a pivotal role in urologic care by enabling drainage of the upper urinary tract across a wide spectrum of indications, including obstructive stone disease, malignant compression, and benign strictures. Technological progression over recent years has moved the field beyond simple polymer tubes toward devices that incorporate advanced materials, surface treatments, and geometry designed to improve patient comfort, reduce encrustation, and extend indwelling lifespans. Clinicians and health system leaders increasingly evaluate stent selection not only on immediate clinical performance but also on downstream impacts such as readmission rates, procedural repeat interventions, and total cost of care.

From a clinical perspective, the balance among ease of insertion, radiopacity, resistance to biofilm formation, and removal logistics remains the core determinant of device adoption. At the same time, the market environment is shaped by rising ambulatory procedures, payer scrutiny of device-related episode costs, and regulatory expectations for safety and post-market surveillance. Consequently, strategic planning for manufacturers, providers, and procurement organizations must incorporate both clinical evidence and operational levers to maintain alignment with evolving standards of care and patient experience priorities.

How advances in material science, antimicrobial technologies, and evolving care delivery models are redefining clinical practice and commercial strategy in ureteral stent systems

The landscape for ureteral stent systems is being reshaped by several transformative shifts that are simultaneously clinical, technological, and organizational. Advances in materials science, including biodegradable polymers and nitinol alloys with refined surface finishes, are creating new product categories that seek to reduce complications such as encrustation and migration. Parallel progress in drug-eluting coatings and antimicrobial surface technologies is addressing infection and biofilm risk, enabling clinicians to consider stent therapies across broader indications and longer indwelling times. Moreover, additive manufacturing and precision engineering have opened opportunities for more individualized stent geometries and patient-specific solutions, although regulatory and production scaling remain practical constraints.

Operationally, care delivery is migrating toward ambulatory settings where shorter procedural times and faster patient turnover are prioritized. This shift is supported by improvements in pain control protocols and device designs that facilitate easier placement and removal. Supply chain dynamics, including sourcing of specialty materials and manufacturing consolidation, are encouraging strategic partnerships and vertical integration among component suppliers, device manufacturers, and contract manufacturers. Together, these transformations are elevating the importance of R&D velocity, real-world outcome data, and collaborative commercialization strategies in determining which technologies achieve market traction.

Operational and strategic repercussions of new cumulative tariff measures on procurement, manufacturing resilience, and value-based contracting within the ureteral stent ecosystem

The implementation of new tariff measures in the United States has introduced a complex set of headwinds and strategic responses across the ureteral stent value chain. Import levies on key raw materials and finished components have increased landed costs for manufacturers that rely on global suppliers, particularly for specialty polymers and metal alloys. In response, many firms have initiated tactical actions including renegotiation of supply contracts, inventory optimization, and selective nearshoring of critical production inputs to reduce exposure to transoceanic tariff volatility. These moves, however, require upfront capital and time to validate quality systems and regulatory compliance for new manufacturing locations.

Beyond procurement, tariff-driven cost pressures are influencing pricing discussions with institutional buyers and payers. Health systems facing constrained budgets are scrutinizing total cost of care implications and may favor devices that demonstrably reduce downstream resource use, such as those that minimize reintervention. Consequently, manufacturers are adjusting commercial models to emphasize value articulation and to offer bundled solutions that align with provider incentives. In parallel, some innovators are accelerating domestic manufacturing and supply chain diversification to insulate distribution continuity and to meet procurement preferences for locally sourced medical devices.

Deep segmentation insights connecting end users, material innovation, device typologies, clinical indications, and distribution pathways to strategic commercialization decisions

A granular understanding of clinical and commercial segmentation is essential for navigating product development and go-to-market strategies in the ureteral stent domain. When examining end users, the market bifurcates across ambulatory surgical centers, clinics, and hospitals; within ambulatory surgical centers there are distinct dynamics between hospital-owned facilities and physician-owned centers, while hospitals themselves present differential procurement patterns across private and public institutions. From a materials perspective, product offerings are distinguished by biodegradable options such as polycaprolactone and PLGA, metal stents built from nickel-titanium and stainless steel alloys, and polymeric devices typically manufactured from PVC or silicone; each material family has tradeoffs in terms of biocompatibility, flexibility, radiopacity, and manufacturing complexity.

Product type segmentation includes classic double J configurations, resonance metallic constructions designed for long-term patency, and self-expanding models engineered to maintain luminal flow under extrinsic compression. Clinical indications further refine targeting, with stents deployed for calculi management, for relief of obstructions that may be benign or malignant in origin, and for treatment of strictures where dwell time and migration risk are critical considerations. Distribution channels span e-commerce platforms with B2B and B2C portals, direct hospital sales for institutional purchasing, and retail pharmacies that operate through chain and independent outlets; each channel imposes different logistics, contracting, and regulatory implications for manufacturers and distributors. Integrating these segmentation lenses supports prioritization of R&D investments, tailored clinical evidence generation, and differentiated commercial approaches aligned with the needs of specific end users and payers.

How regional regulatory environments, reimbursement dynamics, and care delivery trends across the Americas, Europe Middle East and Africa, and Asia Pacific shape adoption and access

Regional dynamics exert a pronounced influence on regulatory frameworks, reimbursement practices, and clinical adoption patterns for ureteral stent systems across global markets. In the Americas, diverse payer structures and a concentration of advanced tertiary centers drive demand for differentiated device features and evidence packages that justify higher unit costs when offset by reduced downstream interventions. Conversely, procurement in many parts of the region is increasingly guided by value-based purchasing decisions that emphasize total episode outcomes rather than device list price alone. In Europe, Middle East & Africa, regulatory harmonization efforts and centralized procurement in some jurisdictions create opportunities for manufacturers that can demonstrate consistent clinical performance and compliant supply chains, while country-level heterogeneity in reimbursement and clinical pathways requires adaptive market entry strategies.

In the Asia-Pacific region, rapid expansion of ambulatory services and rising investments in minimally invasive urology support accelerated uptake of innovative stent designs, but pricing sensitivity and fragmented distribution networks necessitate flexible commercialization models. Local manufacturing capabilities and partnerships with regional distributors are often critical for scaling access and meeting regulatory timelines. Across all regions, differences in clinical practice patterns, incidence of stone disease, and infrastructure for follow-up care shape the real-world performance expectations for stents, making region-specific evidence generation and tailored sales approaches vital for long-term adoption.

Strategic behaviors and operational priorities of prominent manufacturers focusing on innovation, evidence generation, and supply chain resilience to secure clinical uptake

Leading organizations in the ureteral stent sector are pursuing a mix of organic innovation, strategic collaborations, and targeted acquisitions to build differentiated portfolios and to accelerate time to market. Investment priorities commonly include biodegradable material platforms, coated surfaces that reduce encrustation and infection risk, and engineered geometries that improve patient comfort and anchoring. Companies are also strengthening clinical evidence generation through investigator-initiated studies, registry partnerships, and real-world evidence programs to support both regulatory filings and payer discussions. These efforts are often complemented by commercial strategies that integrate training programs for clinicians, procedural support, and bundled service offerings intended to de-risk adoption for hospital systems.

Operationally, market leaders are optimizing manufacturing footprints and supply chain resilience to ensure continuity in the face of global disruptions and policy shifts. Collaboration with contract manufacturers and strategic suppliers enables scalable production while maintaining quality oversight, whereas forward-looking players are exploring nearshore capacity to reduce lead times and tariff exposure. On the commercial front, organizations are diversifying distribution models to include direct sales to hospitals, digital channels for physician engagement, and partnerships with retail chains and pharmacy networks to broaden patient access. Collectively, these approaches reflect a maturation of industry tactics from single-product promotion to integrated solutions that address clinical outcomes, economics, and lifecycle support.

Actionable strategic priorities and operational measures for manufacturers and health systems to accelerate clinical adoption and build resilient, value-driven business models

Industry leaders should prioritize a set of actionable measures that align R&D, manufacturing, and commercial execution to prevailing clinical and economic demands. First, focusing development resources on materials and coatings that demonstrably reduce complications will strengthen value propositions to payers and providers, while parallel investments in robust clinical evidence and registries will accelerate acceptance in both ambulatory and inpatient settings. Second, diversifying manufacturing and supplier networks through selective nearshoring and validated secondary sources will limit tariff and logistics exposure and preserve delivery reliability for institutional customers. Third, companies should refine commercial models to align with bundled care arrangements and outcomes-based purchasing, offering performance guarantees or service packages that integrate device, training, and follow-up support.

Additionally, firms should develop differentiated channel strategies that recognize the distinct needs of hospital procurement, ambulatory centers, and pharmacy networks, while leveraging digital engagement and telehealth integration to support pre- and post-procedural care. Collaborative partnerships with clinical leaders and health systems can yield real-world data and facilitate guideline inclusion. Finally, operational investments in regulatory strategy, quality systems, and post-market surveillance will expedite approvals in multiple jurisdictions and mitigate compliance risk, enabling scalable adoption across diverse healthcare environments.

Transparent research approach combining stakeholder interviews, clinical literature synthesis, regulatory verification, and data triangulation to underpin actionable insights

The research underpinning this executive summary synthesizes primary qualitative insights and comprehensive secondary analysis to ensure balanced and validated findings. Primary research included structured interviews with practicing urologists, procurement leaders in ambulatory and hospital settings, clinical trial investigators, and supply chain executives, providing real-world perspectives on device performance, procurement drivers, and clinical workflow considerations. Secondary sources comprised peer-reviewed clinical literature, regulatory filings, material science publications, and publicly available product labeling and adverse event reports; these sources informed technical assessments of materials, coatings, and device architectures.

Data triangulation techniques were applied to reconcile potential discrepancies across sources, and evidence weighting prioritized high-quality clinical data and stakeholder consensus where available. Quality assurance steps included cross-checking regulatory status and approval timelines, validating manufacturing locations and capabilities through supplier disclosures, and verifying distribution channel characteristics via trade publications and health system procurement policies. Throughout the research process, attention was paid to transparency in data sourcing and clarity in assumptions to support robust strategic interpretation without reliance on proprietary market sizing projections.

Concise synthesis of clinical, technological, and operational trends defining competitive advantage and adoption pathways in ureteral stent systems

In summary, the ureteral stent system landscape is evolving at the intersection of material innovation, shifting care settings, and heightened expectations for value and safety. Advances in biodegradable polymers, engineered metallic designs, and antimicrobial surface technologies are expanding therapeutic choices for clinicians while introducing new considerations for manufacturing, regulation, and reimbursement. At the same time, the growing role of ambulatory care, pressure on episode costs, and supply chain sensitivities require manufacturers to align product development with demonstrable clinical outcomes and operational resilience.

Looking ahead, success in this sector will favor organizations that can combine technical differentiation with rigorous clinical evidence, flexible manufacturing strategies, and commercial models that support value-based adoption. Health systems and clinicians will increasingly select stent solutions that reduce reintervention risk, simplify care pathways, and integrate with broader urologic treatment strategies. By focusing on these integrated priorities, stakeholders across the value chain can better navigate the complexities of device selection, procurement, and long-term patient management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ureteral Stent System Market, by Material

  • 8.1. Biodegradable
    • 8.1.1. Pcl
    • 8.1.2. Plga
  • 8.2. Metal
    • 8.2.1. Nickel Titanium
    • 8.2.2. Stainless Steel
  • 8.3. Polymer
    • 8.3.1. Pvc
    • 8.3.2. Silicone

9. Ureteral Stent System Market, by Product Type

  • 9.1. Double J
  • 9.2. Resonance Metallic
  • 9.3. Self Expanding

10. Ureteral Stent System Market, by Indication

  • 10.1. Calculi
  • 10.2. Obstruction
    • 10.2.1. Benign
    • 10.2.2. Malignant
  • 10.3. Stricture

11. Ureteral Stent System Market, by End User

  • 11.1. Ambulatory Surgical Centers
    • 11.1.1. Hospital Owned
    • 11.1.2. Physician Owned
  • 11.2. Clinics
  • 11.3. Hospitals
    • 11.3.1. Private
    • 11.3.2. Public

12. Ureteral Stent System Market, by Distribution Channel

  • 12.1. E-Commerce
    • 12.1.1. B2B Portals
    • 12.1.2. B2C Portals
  • 12.2. Hospital Sales
  • 12.3. Retail Pharmacies
    • 12.3.1. Chain
    • 12.3.2. Independent

13. Ureteral Stent System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ureteral Stent System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ureteral Stent System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Ureteral Stent System Market

17. China Ureteral Stent System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Allium Medical Solutions Ltd.
  • 18.6. Amecath Medical Technologies
  • 18.7. Applied Medical Resources Corporation
  • 18.8. B. Braun Melsungen AG
  • 18.9. Becton, Dickinson and Company
  • 18.10. Boston Scientific Corporation
  • 18.11. Coloplast A/S
  • 18.12. Conmed Corporation
  • 18.13. Cook Medical LLC
  • 18.14. EuroTec
  • 18.15. JOLINE GmbH & Co. KG
  • 18.16. Labotronix
  • 18.17. Medi-Globe GmbH
  • 18.18. Merit Medical Systems Inc.
  • 18.19. Micro-Tech (Nanjing) Co., Ltd.
  • 18.20. Olympus Corporation
  • 18.21. Optimed Medizinische Instrumente GmbH
  • 18.22. Porges S.A.
  • 18.23. Rocamed SAS
  • 18.24. Stryker Corporation
  • 18.25. Taewoong Medical Co., Ltd.
  • 18.26. Teleflex Incorporated
  • 18.27. Urocare Products Inc.
  • 18.28. Uromedica, Inc.
  • 18.29. Urotech GmbH
  • 18.30. Urovision GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL URETERAL STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL URETERAL STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PCL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PCL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PCL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PLGA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PLGA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PLGA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY NICKEL TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY NICKEL TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY NICKEL TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY DOUBLE J, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY DOUBLE J, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY DOUBLE J, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RESONANCE METALLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RESONANCE METALLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RESONANCE METALLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CALCULI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CALCULI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CALCULI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BENIGN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BENIGN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BENIGN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PHYSICIAN OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PHYSICIAN OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PHYSICIAN OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2B PORTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2B PORTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2B PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2C PORTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2C PORTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2C PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CHAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CHAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 236. GCC URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. GCC URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 239. GCC URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 240. GCC URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 241. GCC URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 243. GCC URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 244. GCC URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. GCC URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 246. GCC URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. GCC URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 249. GCC URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 278. G7 URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. G7 URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 280. G7 URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 281. G7 URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 282. G7 URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 283. G7 URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. G7 URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 285. G7 URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 286. G7 URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. G7 URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 288. G7 URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. G7 URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 291. G7 URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 292. NATO URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. NATO URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 294. NATO URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 295. NATO URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 296. NATO URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 297. NATO URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 299. NATO URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 300. NATO URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. NATO URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 302. NATO URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 303. NATO URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 304. NATO URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 305. NATO URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)